Christina R. Ross

This study examines four mouse breast cancer models to show that oncogenic drivers influence metastasis-specific copy number variations and gene expression, while genetic background also plays a significant role.

The paper identifies Smarcd1 as a 'Goldilocks' metastasis modifier gene, showing that both high and low expression correlate with better clinical outcomes, while intermediate expression worsens survival in breast cancer.